A case of M-BCR-rearranged, Philadelphia-positive AML that relapsed as chronic phase CML

Progression free survival of myeloma patients who become IFE-negative correlates with the detection of residual monoclonal free light chain (FLC) by mass spectrometry.

Blood cancer journal·2024

Combination of flow cytometry and functional imaging for monitoring of residual disease in myeloma.

Leukemia·2018

Spatial genomic heterogeneity in multiple myeloma revealed by multi-region sequencing.

Nature communications·2017

Carfilzomib resistance due to ABCB1/MDR1 overexpression is overcome by nelfinavir and lopinavir in multiple myeloma.

Leukemia·2017

Prediction of outcome in newly diagnosed myeloma: a meta-analysis of the molecular profiles of 1905 trial patients.

Leukemia·2017

Overexpression of EZH2 in multiple myeloma is associated with poor prognosis and dysregulation of cell cycle control.

Blood cancer journal·2017

A multicenter phase II study of glofitamab plus polatuzumab-R-CHP for patients with diffuse large B-cell lymphoma.

Blood·2026

EVIDENCE OF CLL DEVELOPMENT FROM HEMATOPOIETIC PROGENITOR CELLS IN HUMANS.

Blood·2026

Telomere length in chronic lymphocytic leukemia treated with venetoclax-based regimen in GAIA/CLL13 and CLL2-GIVe trials.

Blood·2026

TLR9-dependent migration identifies different Chronic Lymphocytic Leukemia signaling states under BTK inhibition.

Blood·2026

Mosunetuzumab and Polatuzumab Vedotin as First-line Treatment for Large B Cell Lymphoma in Older Unfit or Frail Patients.

Blood·2026

STAG2 mutations fine-tune the ALK-driven oncogenic program in ALK-positive anaplastic large cell lymphoma.

Blood·2026

Triple M Overlap Syndrome: A Rare Complication of Immune Checkpoint Inhibitors.

Cureus·2026

Long-term mutational analysis, clonal metrics, and dynamics in patients with chronic idiopathic neutropenia.

HemaSphere·2026

Establishing environmental causes of childhood cancer: a view from the IARC Monographs.

UCL open. Environment·2026

Passive E06 IgG reduces lesional PC-OxPL and macrophage accumulation in cholesterol-fed Ldlr-/- mice.

Atherosclerosis plus·2026

Neuro-immune-bone axis in post-traumatic bone regeneration: temporal regulation, dysregulation mechanisms, and therapeutic implications.

Frontiers in immunology·2026

Innate immune signaling-driven myeloid remodeling in cancer: inflammatory amplification, immune suppression, and therapeutic targeting.

Frontiers in immunology·2026

Related Experiment Videos

A case of M-BCR-rearranged, Philadelphia-positive AML that relapsed as chronic phase CML

Related Concept Videos

Progression free survival of myeloma patients who become IFE-negative correlates with the detection of residual monoclonal free light chain (FLC) by mass spectrometry.

Combination of flow cytometry and functional imaging for monitoring of residual disease in myeloma.

Spatial genomic heterogeneity in multiple myeloma revealed by multi-region sequencing.

Carfilzomib resistance due to ABCB1/MDR1 overexpression is overcome by nelfinavir and lopinavir in multiple myeloma.

Prediction of outcome in newly diagnosed myeloma: a meta-analysis of the molecular profiles of 1905 trial patients.

Overexpression of EZH2 in multiple myeloma is associated with poor prognosis and dysregulation of cell cycle control.

A multicenter phase II study of glofitamab plus polatuzumab-R-CHP for patients with diffuse large B-cell lymphoma.

EVIDENCE OF CLL DEVELOPMENT FROM HEMATOPOIETIC PROGENITOR CELLS IN HUMANS.

Telomere length in chronic lymphocytic leukemia treated with venetoclax-based regimen in GAIA/CLL13 and CLL2-GIVe trials.

TLR9-dependent migration identifies different Chronic Lymphocytic Leukemia signaling states under BTK inhibition.

Mosunetuzumab and Polatuzumab Vedotin as First-line Treatment for Large B Cell Lymphoma in Older Unfit or Frail Patients.

STAG2 mutations fine-tune the ALK-driven oncogenic program in ALK-positive anaplastic large cell lymphoma.

Triple M Overlap Syndrome: A Rare Complication of Immune Checkpoint Inhibitors.

Long-term mutational analysis, clonal metrics, and dynamics in patients with chronic idiopathic neutropenia.

Establishing environmental causes of childhood cancer: a view from the IARC Monographs.

Passive E06 IgG reduces lesional PC-OxPL and macrophage accumulation in cholesterol-fed Ldlr-/- mice.

Neuro-immune-bone axis in post-traumatic bone regeneration: temporal regulation, dysregulation mechanisms, and therapeutic implications.

Innate immune signaling-driven myeloid remodeling in cancer: inflammatory amplification, immune suppression, and therapeutic targeting.

Related Experiment Videos

A case of M-BCR-rearranged, Philadelphia-positive AML that relapsed as chronic phase CML

Related Concept Videos

Related Articles